0001562180-15-000578.txt : 20150721
0001562180-15-000578.hdr.sgml : 20150721
20150721174552
ACCESSION NUMBER: 0001562180-15-000578
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150720
FILED AS OF DATE: 20150721
DATE AS OF CHANGE: 20150721
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intersect ENT, Inc.
CENTRAL INDEX KEY: 0001271214
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 200280837
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-641-2100
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: SINEXUS INC
DATE OF NAME CHANGE: 20031124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stambaugh James
CENTRAL INDEX KEY: 0001614498
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36545
FILM NUMBER: 15998595
MAIL ADDRESS:
STREET 1: 1555 ADAMS DRIVE
STREET 2: C/O INTERSECT ENT, INC.
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2015-07-20
false
0001271214
Intersect ENT, Inc.
XENT
0001614498
Stambaugh James
C/O INTERSECT ENT, INC., 1555 ADAMS DR.
MENLO PARK
CA
94025
false
true
false
false
VP Clinical Affairs
Common Stock
2015-07-20
4
M
false
12000.00
0.48
A
12000.00
D
Common Stock
2015-07-20
4
S
false
12000.00
30.5174
D
0.00
D
Stock Option (right to buy)
0.48
2015-07-20
4
M
false
12000.00
0.00
D
2016-11-16
Common Stock
12000.00
27062.00
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 13, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.23 to $30.92, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning October 23, 2007.
/s/ Jeryl L. Hilleman, Attorney-in-Fact for James W. Stambaugh
2015-07-21